ArticleESMO real world data and digital oncology2026

UK real-world evidence on pembrolizumab and neoadjuvant chemotherapy for early-stage triple-negative breast cancer.

J McKeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.